E-viri
Recenzirano
Odprti dostop
-
Albertsson-Wikland, Kerstin; Aronson, A. Stefan; Gustafsson, Jan; Hagenäs, Lars; Ivarsson, Sten A; Jonsson, Björn; Kriström, Berit; Marcus, Claude; Nilsson, Karl Olof; Ritzén, E. Martin; Tuvemo, Torsten; Westphal, Otto; Åman, Jan
The journal of clinical endocrinology and metabolism, 2008, Letnik: 93, Številka: 11Journal Article
Context: The effect of GH therapy in short non-GH-deficient children, especially those with idiopathic short stature (ISS), has not been clearly established owing to the lack of controlled trials continuing until final height (FH). Objective: The aim of the study was to investigate the effect on growth to FH of two GH doses given to short children, mainly with ISS, compared with untreated controls. Design and Setting: A randomized, controlled, long-term multicenter trial was conducted in Sweden. Intervention: Two doses of GH (Genotropin) were administered, 33 or 67 μg/kg·d; control subjects were untreated. Subjects: A total of 177 subjects with short stature were enrolled. Of these, 151 were included in the intent to treat (AllITT) population, and 108 in the per protocol (AllPP) population. Analysis of ISS subjects included 126 children in the ITT (ISSITT) population and 68 subjects in the PP (ISSPP) population. Main Outcome Measures: We measured FH sd score (SDS), difference in SDS to midparenteral height (diff MPHSDS), and gain in heightSDS. Results: After 5.9 ± 1.1 yr on GH therapy, the FHSDS in the AllPP population treated with GH vs. controls was −1.5 ± 0.81 (33 μg/kg·d, −1.7 ± 0.70; and 67 μg/kg·d, −1.4 ± 0.86; P < 0.032), vs. −2.4 ± 0.85 (P < 0.001); the diff MPHSDS was −0.2 ± 1.0 vs. −1.0 ± 0.74 (P < 0.001); and the gain in heightSDS was 1.3 ± 0.78 vs. 0.2 ± 0.69 (P < 0.001). GH therapy was safe and had no impact on time to onset of puberty. A dose-response relationship identified after 1 yr remained to FH for all growth outcome variables in all four populations. Conclusion: GH treatment significantly increased FH in ISS children in a dose-dependent manner, with a mean gain of 1.3 SDS (8 cm) and a broad range of response from no gain to 3 SDS compared to a mean gain of 0.2 SDS in the untreated controls.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.